- Investing Ideas
- /
- Global Potentially Undervalued Companies
Global Potentially Undervalued Companies
UPDATED Jun 02, 2024
Companies with a Value score of at least 3, ordered by Value score
33,498 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
6929 | HK$3.83 | -24.5% | n/a | HK$3.2b | HK$9.06 | PE10.6x | E7.6% | n/a | Healthcare | ||
506 | HK$2.84 | -0.4% | 15.0% | HK$7.8b | HK$3.90 | PE9.4x | E5.9% | 4.5% | Food, Beverage & Tobacco | ||
SIA | €136.72 | 1.3% | 32.2% | €106.4b | €180.58 | PE11.8x | E1.2% | 3.2% | Capital Goods | ||
CRR | €17.28 | 1.5% | 6.3% | €12.6b | €21.14 | PE12.2x | E6.7% | 3.0% | Consumer Retailing | ||
NTR | US$0.93 | 0.5% | 11.6% | US$209.9m | US$1.13 | PS8.2x | E67.3% | n/a | Pharmaceuticals & Biotech | ||
AU61 | R7.40 | -2.6% | 2.8% | R123.7b | R9.42 | PB0.8x | E11.8% | 9.2% | Banks | ||
53L | CA$8.95 | 1.7% | -6.3% | CA$1.2b | CA$12.48 | PE12x | E12.1% | 6.6% | Materials | ||
MGS | €12.70 | 4.1% | 5.8% | €57.4m | €18.00 | PE8.4x | E10.4% | n/a | Materials | ||
0N9Z | €30.20 | 0% | 38.5% | €405.0m | €39.73 | PE11x | E2.9% | 3.6% | Tech | ||
ECVT | US$9.30 | 0% | -10.9% | US$1.1b | US$13.86 | PE14.7x | E29.1% | n/a | Materials | ||
JBI | US$13.88 | -4.1% | 53.0% | US$2.0b | US$17.93 | PE14.4x | E10.1% | n/a | Capital Goods | ||
PIG | US$25.08 | -3.1% | -15.1% | US$3.8b | US$35.98 | PE4691.1x | E49.3% | 4.0% | Pharmaceuticals & Biotech | ||
MIF | US$20.20 | 2.5% | 34.7% | US$7.0b | US$27.49 | PE19.3x | E17.0% | 0% | Retail | ||
GRP.U | CA$49.43 | -1.1% | -20.4% | CA$4.2b | CA$64.08 | PB0.8x | E16.7% | 4.9% | Real Estate | ||
ECPG | US$44.24 | 1.1% | -5.1% | US$1.0b | US$61.00 | PB1.1x | E128.6% | n/a | Diversified Financials | ||
ENOV | US$50.27 | 0.06% | -10.6% | US$2.8b | US$74.10 | PS1.5x | E106.2% | n/a | Healthcare | ||
RBBN | US$3.14 | 1.0% | 7.2% | US$546.1m | US$6.00 | PB1.3x | S5.2% | n/a | Tech | ||
ADH | AU$1.73 | -0.6% | 7.1% | AU$299.6m | AU$2.16 | PE8.9x | E13.2% | 5.8% | Retail | ||
PFC | US$19.71 | -2.5% | 29.1% | US$705.9m | US$23.75 | PB0.7x | E-16.1% | 6.3% | Banks | ||
2007 | CN¥18.17 | -1.8% | -17.6% | CN¥33.2b | CN¥25.84 | PE23.9x | E18.0% | 1.7% | Pharmaceuticals & Biotech | ||
300760 | CN¥290.14 | -4.0% | -3.8% | CN¥350.9b | CN¥393.76 | PE28.8x | E15.1% | 2.0% | Healthcare | ||
2IVB | UK£17.00 | 8.3% | -2.9% | UK£1.9b | UK£28.51 | PE496.3x | E34.7% | 0% | Pharmaceuticals & Biotech | ||
BYD | US$53.32 | 3.0% | -19.6% | US$5.1b | US$69.79 | PE9.1x | E3.8% | 1.3% | Consumer Services | ||
FGR | €101.35 | 0.6% | 1.1% | €9.5b | €126.95 | PE9.4x | E5.2% | 4.0% | Capital Goods |